Cue Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05 2022 - 4:01PM
Business Wire
Cue Health (“Cue”) (Nasdaq:HLTH), a healthcare technology
company, announced today that its management team will present at
the 40th Annual J.P. Morgan Healthcare Conference on Tuesday,
January 11, 2022 at 5:15 p.m. Eastern Time.
A live audio webcast and replay of the presentation may be
accessed for 30 days on the “Investor Relations” section of the
company’s website at: www.cuehealth.com.
About Cue Health Cue Health (Nasdaq:HLTH) is a healthcare
technology company that makes it easy for individuals to access
health information and places diagnostic information at the center
of care. Cue Health enables people to manage their health through
real-time, actionable, and connected health information, offering
individuals and their healthcare providers easy access to
lab-quality diagnostics anywhere, anytime, in a device that fits in
the palm of the hand. Cue Health's first-of-its-kind COVID-19 test
was the first FDA-authorized molecular diagnostic test for at-home
and over-the-counter use without a prescription and physician
supervision. Outside the United States, Cue Health has received the
CE mark in the European Union, Interim Order authorization from
Health Canada, regulatory approval from India's Central Drugs
Standard Control Organisation, and PSAR authorization from
Singapore's Health Sciences Authority. Cue was founded in 2010 and
is headquartered in San Diego. For more information, please visit
www.cuehealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220105005186/en/
ICR Westwicke Caroline Corner ir@cuehealth.com (415)
202-5678
Cue Health press@cuehealth.com
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jul 2023 to Jul 2024